Penn's Kiran Musunuru spoke with The Inquirer about the future of CRISPR technology.

Lawmakers are trying to restore access to GLP-1 weight loss drugs, like Ozempic and Wegovy, after Ohio removed medical ...

Six months into his second term, 42% of Americans approve of the job President Trump is doing, a new CBS News poll finds.

SHOPPING: Take charge of your health with help from Hims, the weight loss program that puts your specific needs front and ...

Some health experts view GLP-1s as a promising option for PCOS, which lacks a standard treatment and affects millions of ...

Our data show mitochondrial diseases affect ≈1 in 5000 newborns and cost families ...

Obesity is when the human body accumulates excess body fat to the extent it can have negative effects on health. Obesity is a medical condition considered by many as a ...

Sharon Osbourne lost weight with the help of Ozempic after calling herself a 'food addict' and ultimately warning against the ...

That's what happened beginning in November of last year, anyway. The company announced solid testing results for VK2735. But ...

AI scanned animal venom peptides and found 386 potential antibiotics. Most killed drug-resistant bacteria in tests and were ...

On April 29, 2025, Hims & Hers and Novo Nordisk unveiled a landmark collaboration to bring Wegovy—Novo's blockbuster ...

Sino Biopharma will acquire LaNova Medicines, which has licensed cancer drugs for Merck and AstraZeneca, for $951 million.